A cholecystokinin receptor antagonist inhibits chondrocyte hypertrophy and protein kinase a activity decrease induced by activation of GPR22. (April 2016) - Guns, L.-A.K.; Calebiro, D.; Lohse, M.J.; Lories, R.; Cailotto, F.